I would like to know what is our net debt as on 31st December?
Okay. And what would be our subsidy receivable as on 31st December?
Questions across 11 calls
Saumil Shah
Paras Investments
Paradeep Phosphates Limited
Yes. Hi. Good evening, management. So, my question is on this Rs. 3,600 crore Capex. So, this Capex, what we are doing, so what will be our asset turn on that Capex?
2x to 2.5x. And by when you think that we can reach the peak capacity in this plant.
Natco Pharma Limited
I wanted to know more on your acquisition of Adcock. I mean, by when this transaction will be completed and how much it will add to our bottom line? So I think they are doing a yearly run rate of around INR5,000 crores, and we hold about 35% in that?
Okay. So total PAT is around $48 million?
Hi, sir. Good morning. Sir, we have this other income of 76 crores in this quarter. So , what is that for? And if this was not there, we would have ended up doing a loss in this quarter.
From sale of land, 90 crores.
Congrats on a very good set of numbers. Sir, last month, we had given a notification that Mylan and Novo have reached on a settlement for the Ozempic drug. So could you throw some light by when we can expect this product in India market and by when in U.S. market? When do we expect to get FDA approval? Any time lines or your views on the development?
Okay. So if no challenges, then by FY '27, we can expect?
Sir, congratulations on a good set of numbers. Sir, in the previous call, you mentioned that most of our Revlimid quota was done for this year. And next quarter, there won't be much quantity left. But still the performance for this quarter in terms of sales was very good. So, does that mean that our other products did really well in this quarter?
Okay. And that performance can continue further for the next quarters, non-Revlimid?
So congratulations on a good set of numbers. So I wanted to know the impact of eight observations for our Kothur plant on our revenue for the current quarter. And by when we can clear these observations because it's almost a month now?
Okay. So even if this, I mean, currently since the observations are there, so the production has been moved to the other plant?
Manappuram Finance Limited
Sir, how is the current quarter shaping up? I mean we were expecting to cross INR850 crores in the current financial year. So are we on track to achieve it?
And sir, in terms of EBITDA, I mean, we were at the lowest in terms of EBITDA, 14% in last many years. So I mean, how is the current quarter shaping up? And by FY '26, where do we see the EBITDA margin settling down?
HEG Limited
On consolidated basis our EBITDA margin is in the range of 17% for this quarter. So where do we see this range settling for the remaining half of this year?
Considering the current demand scenario any guidance you would like to give for FY26?
Data Patterns (India) Limited
Hi, sir. Our order inflow for the past 6 months is just INR83 crores. So, why is it so less? Any particular reason for that? Are we facing any competition or something like that?
Okay. So, basically, what we have guided for INR700 crores to INR800 crores for this year extends, I mean, we can get to that order book.
Syrma SGS Technology Limited
Hi, thanks for the opportunity. My question is on the capex side. You just mentioned that we'll be doing INR130 crores of capex for the next two years. And as we are growing at a 35%-40% CAGR growth, so back of the envelope calculation by FY '27, we should be reaching about INR8,000 crores of revenue, approx. So, will this capex be enough to generate that revenue?
So, you just mentioned INR130 crores-INR150 crores of capex, Bijay?